We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-2.65%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$3.16B
AUM Growth
-$738M
Cap. Flow
-$649M
Cap. Flow %
-20.54%
Top 10 Hldgs %
17.54%
Holding
750
New
208
Increased
146
Reduced
154
Closed
235

Sector Composition

Rank Sector Weight
1 Real Estate 13.02%
2 Consumer Discretionary 8.61%
3 Industrials 6.83%
4 Technology 6.65%
5 Utilities 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
451
Vanda Pharmaceuticals
VNDA
$314M
$674K 0.02%
40,000
-10,000
-20% -$167K
ZOES
452
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
$671K 0.02%
+46,500
New +$698K
CBIO
453
Crescent Biopharma
CBIO
$626M
$649K 0.02%
+400
New +$832K
NVS icon
454
Novartis
NVS
$297B
$647K 0.02%
8,928
+1,116
+14% +$85K
TCMD icon
455
Tactile Systems Technology
TCMD
$626M
$636K 0.02%
20,000
-5,000
-20% -$155K
UAL icon
456
United Airlines
UAL
$39.1B
$620K 0.02%
8,928
-63,072
-88% -$4.36M
MMM icon
457
3M
MMM
$91.9B
$612K 0.02%
+3,337
New +$661K
BRFS
458
DELISTED
BRF SA
BRFS
$596K 0.02%
86,175
-118,925
-58% -$1.15M
TSRO
459
DELISTED
TESARO, Inc.
TSRO
$554K 0.02%
9,700
-15,300
-61% -$984K
CBAY
460
DELISTED
Cymabay Therapeutics
CBAY
$533K 0.02%
41,000
+16,000
+64% +$199K
NKTR icon
461
Nektar Therapeutics
NKTR
$2.41B
$531K 0.02%
+333
New +$429K
CSII
462
DELISTED
Cardiovascular Systems, Inc.
CSII
$529K 0.02%
24,100
-900
-4% -$21.6K
PRTK
463
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$520K 0.02%
40,000
+5,000
+14% +$74.4K
BKS
464
DELISTED
Barnes & Noble
BKS
$495K 0.02%
100,000
-48,700
-33% -$244K
FDX icon
465
FedEx
FDX
$73.5B
$493K 0.02%
+2,052
New +$519K
NVR icon
466
NVR
NVR
$16.9B
$490K 0.02%
+175
New +$556K
BMCH
467
DELISTED
BMC Stock Holdings, Inc
BMCH
$482K 0.02%
24,634
-48,370
-66% -$1.03M
VXX
468
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$473K 0.02%
10,000
+2,300
+30% +$87.2K
DPLO
469
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$453K 0.01%
22,500
+2,500
+13% +$58.3K
PETX
470
DELISTED
Aratana Therapeutics, Inc.
PETX
$441K 0.01%
100,000
+40,000
+67% +$178K
TYME
471
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$424K 0.01%
+190,000
New +$775K
MAS icon
472
Masco
MAS
$16.4B
$419K 0.01%
10,350
-96,750
-90% -$4.16M
PDCO
473
DELISTED
Patterson Companies, Inc.
PDCO
$400K 0.01%
18,000
+6,000
+50% +$187K
USFD icon
474
US Foods
USFD
$21.9B
$393K 0.01%
12,000
-14,000
-54% -$458K
XENT
475
DELISTED
Intersect ENT, Inc
XENT
$393K 0.01%
+10,000
New +$365K

Similar funds

Weiss Multi-Strategy Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Weiss Multi-Strategy Advisers held 750 positions worth $3.16B, down 19% from $3.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $649M in Q1 2018, closing 235 positions and reducing 154 holdings. Its most notable exit was Johnson & Johnson, an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 13% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in VICI Properties worth $48.9M.

  • Weiss Multi-Strategy Advisers's largest Q1 2018 buy was VICI Properties: 2,668,289 shares worth $48.9M.
  • Weiss Multi-Strategy Advisers added most to Canadian National Railway in Q1 2018, an estimated $29.6M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $597M.
  • Weiss Multi-Strategy Advisers fully exited Johnson & Johnson in Q1 2018, selling an estimated $30.3M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 18% of its $3.16B portfolio in Q1 2018.
  • Weiss Multi-Strategy Advisers opened 208 new positions and closed 235 in Q1 2018.
  • Weiss Multi-Strategy Advisers's portfolio value fell 19% quarter-over-quarter to $3.16B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2018, filed 15 May 2018.